| Title | Current Pharmaceutical Analysis |
| Abbreviation | Curr. Pharm. Anal. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Pharmaceutical Science (Q3); Biochemistry (Q4); Biophysics (Q4); Molecular Medicine (Q4) |
| h-index | 29 |
| Overall Rank/Ranking | 19221 |
| SCImago Journal Rank (SJR) | 0.236 |
| Impact Score | 1.50 |
| Publisher | Elsevier B.V. |
| Country | United Arab Emirates |
| ISSN | 1875676X, 15734129 |
| Best Quartile | Q3 |
| Coverage History | 2006-2025 |
Current Pharmaceutical Analysis is a journal covering the technologies/fields/categories related to Pharmaceutical Science (Q3); Biochemistry (Q4); Biophysics (Q4); Molecular Medicine (Q4). It is published by Elsevier B.V.. The overall rank of Current Pharmaceutical Analysis is 19221. According to SCImago Journal Rank (SJR), this journal is ranked 0.236. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 29. The best quartile for this journal is Q3.
The ISSN of Current Pharmaceutical Analysis journal is 1875676X, 15734129. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Current Pharmaceutical Analysis is cited by a total of 335 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of Current Pharmaceutical Analysis is 1.50, which is computed in 2025 as per its definition. Current Pharmaceutical Analysis IF is increased by a factor of 0.73 and approximate percentage change is 94.81% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of Current Pharmaceutical Analysis is 1.50. If the same upward trend persists, Impact IF may rise in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 1.50 |
| 2023 | 0.77 |
| 2022 | 0.66 |
| 2021 | 0.58 |
| 2020 | 0.85 |
| 2019 | 0.86 |
| 2018 | 0.70 |
| 2017 | 0.75 |
| 2016 | 0.88 |
| 2015 | 0.96 |
| 2014 | 0.82 |
Current Pharmaceutical Analysis has an h-index of 29. It means 29 articles of this journal have more than 29 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Current Pharmaceutical Analysis is 1875676X, 15734129. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Current Pharmaceutical Analysis is 19221. According to SCImago Journal Rank (SJR), this journal is ranked 0.236. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.236 |
| 2023 | 0.184 |
| 2022 | 0.178 |
| 2021 | 0.177 |
| 2020 | 0.210 |
| 2019 | 0.286 |
| 2018 | 0.218 |
| 2017 | 0.224 |
| 2016 | 0.242 |
| 2015 | 0.224 |
| 2014 | 0.243 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 19221 |
| 2023 | 20886 |
| 2022 | 20331 |
| 2021 | 19658 |
| 2020 | 18695 |
| 2019 | 14845 |
| 2018 | 16888 |
| 2017 | 16179 |
| 2016 | 15587 |
| 2015 | 16264 |
| 2014 | 15084 |
Current Pharmaceutical Analysis is published by Elsevier B.V.. It's publishing house is located in United Arab Emirates. Coverage history of this journal is as following: 2006-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Current Pharmaceutical Analysis is Curr. Pharm. Anal.. This abbreviation ('Curr. Pharm. Anal.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Pharmaceutical Science (Q3); Biochemistry (Q4); Biophysics (Q4); Molecular Medicine (Q4), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Current Pharmaceutical Analysis latest impact IF is 1.50. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 1.50 (2024) and 0.58 (2021), respectively, in the last 11 years. Moreover, its average IS is 0.85 in the previous 11 years.
The Current Pharmaceutical Analysis has an SJR (SCImago Journal Rank) of 0.236, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 0.286 in 2019 and the lowest being 0.177 in 2021. Furthermore, the average SJR of the Current Pharmaceutical Analysis over the previous 11-year period stands at 0.85.
The latest h-index of the Current Pharmaceutical Analysis is 29.
The Current Pharmaceutical Analysis is published by the Elsevier B.V., with its country of publication being the United Arab Emirates.
The Current Pharmaceutical Analysis is currently ranked 19221 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 14845 in 2019 and its lowest position of 20886 in 2023.
The standard ISO4 abbreviation for the Current Pharmaceutical Analysis is Curr. Pharm. Anal..
Current Pharmaceutical Analysis is classified as a journal that the Elsevier B.V. publishes.
The Current Pharmaceutical Analysis encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Current Pharmaceutical Analysis is assigned the following International Standard Serial Numbers (ISSN): 1875676X, 15734129.
The best quartile for the Current Pharmaceutical Analysis is Q3 (2024).
The Current Pharmaceutical Analysis coverage history can be summarized as follows: 2006-2025.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Applied Ecology and Environmental Research | journal | 19122 | Corvinus University of Budapest | 48 | 0.84 |
| Journal of Geriatric Physical Therapy | journal | 8686 | Lippincott Williams and Wilkins Ltd. | 53 | 1.55 |
| Journal of Business Finance and Accounting | journal | 3244 | Wiley-Blackwell Publishing Ltd | 96 | 3.34 |
| Journal of Classical Sociology | journal | 16960 | SAGE Publications Ltd | 31 | 0.68 |
| Discourse | journal | 7536 | Routledge | 70 | 2.75 |
| Canadian Journal of Education | journal | 15557 | Canadian Society for the Study of Education (CSSE) | 46 | 0.80 |
| British Journal of Special Education | journal | 14055 | Wiley-Blackwell Publishing Ltd | 45 | 1.43 |
| International Conference on Architectural Support for Programming Languages and Operating Systems - ASPLOS | conference and proceedings | 1553 | Association for Computing Machinery | 111 | 7.47 |
| Biological Procedures Online | journal | 5232 | BioMed Central Ltd | 51 | 4.00 |
| Museum Management and Curatorship | journal | 10490 | Routledge | 43 | 2.06 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 1.50 |
| 2023 | 0.77 |
| 2022 | 0.66 |
| 2021 | 0.58 |
| 2020 | 0.85 |
| 2019 | 0.86 |
| 2018 | 0.70 |
| 2017 | 0.75 |
| 2016 | 0.88 |
| 2015 | 0.96 |
| 2014 | 0.82 |
